Exchange: NYSEMkt·Updated 07:30 PM EDT

ELMD News

News
all
press releases
Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates
Electromed (ELMD) delivered earnings and revenue surprises of +21.88% and -2.43%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates
InspireMD (NSPR) delivered earnings and revenue surprises of +15.00% and +7.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates
Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -50.00% and -1.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of +25.00% and -16.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates
Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of +22.22% and -15.00%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
Senseonics (SENS) delivered earnings and revenue surprises of -14.55% and +10.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX
LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help investors navigate market volatility.
Zacks
Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why
Electromed (ELMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Zacks
ELV Accelerates Clinical Reviews Through Health OS Platform
Elevance Health's Health OS is cutting review delays and admin work, with early results showing fewer denials and holds as digital healthcare adoption expands.
Zacks
Here's Why Momentum in Electromed (ELMD) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, Electromed (ELMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Zacks

Advertisement|Remove ads.